EP4216839A1 - Méthode et dispositif pour retirer une thérapie de valve cardiaque - Google Patents

Méthode et dispositif pour retirer une thérapie de valve cardiaque

Info

Publication number
EP4216839A1
EP4216839A1 EP21873270.9A EP21873270A EP4216839A1 EP 4216839 A1 EP4216839 A1 EP 4216839A1 EP 21873270 A EP21873270 A EP 21873270A EP 4216839 A1 EP4216839 A1 EP 4216839A1
Authority
EP
European Patent Office
Prior art keywords
catheter
heart valve
loop
basket
cutting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21873270.9A
Other languages
German (de)
English (en)
Other versions
EP4216839A4 (fr
Inventor
David M. Costello
Daniel P. COYLE
Paul Sorajja
Karl Alexander KABAROWSKI
Brian LINDSHOLM
Alex Alden Peterson
Cole Chen
Michael P. Brenzel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AMX Technologies LLC
Original Assignee
AMX Clip Management LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AMX Clip Management LLC filed Critical AMX Clip Management LLC
Publication of EP4216839A1 publication Critical patent/EP4216839A1/fr
Publication of EP4216839A4 publication Critical patent/EP4216839A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32—Surgical cutting instruments
    • A61B17/3205—Excision instruments
    • A61B17/32056—Surgical snare instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/149—Probes or electrodes therefor bow shaped or with rotatable body at cantilever end, e.g. for resectoscopes, or coagulating rollers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/246—Devices for obstructing a leak through a native valve in a closed condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00287—Bags for minimally invasive surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00358—Snares for grasping
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00778—Operations on blood vessels
    • A61B2017/00783—Valvuloplasty
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831—Material properties
    • A61B2017/00867—Material properties shape memory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
    • A61B2017/2212—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions having a closed distal end, e.g. a loop
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00273—Anchoring means for temporary attachment of a device to tissue
    • A61B2018/00279—Anchoring means for temporary attachment of a device to tissue deployable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00601—Cutting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1405—Electrodes having a specific shape
    • A61B2018/1407—Loop
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1405—Electrodes having a specific shape
    • A61B2018/1407—Loop
    • A61B2018/141—Snare
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1405—Electrodes having a specific shape
    • A61B2018/144—Wire
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1475—Electrodes retractable in or deployable from a housing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2454—Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
    • A61F2/2457—Chordae tendineae prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2466—Delivery devices therefor

Definitions

  • the present disclosure relates to novel and advantageous transcatheter devices and methods to facilitate valvular repair and/or replacement. More specifically, the devices and methods herein relate to the removal of therapies which interact with heart valve leaflets.
  • Heart valve conditions can occur when the leaflets of a patient’s valve are unable to fully close, which allows blood to regurgitate or abnormally flow backward.
  • regurgitation is especially common with the mitral valve 20 in which the mitral valve anterior leaflet 22 fails to properly coapt with the posterior leaflet 24.
  • the mitral valve anterior leaflet 22 fails to properly coapt with the posterior leaflet 24.
  • As the ventricles of the heart 10 contract some blood moves from the left ventricle 14, back into the left atrium 12 instead of into the aorta 11 . Similar regurgitation may also occur with the tricuspid valve 15, allowing blood to flow from the right ventricle 13 back into the right atrium 16.
  • a common treatment for valvular regurgitation is the use of treatment devices that appose or permanently connect the leaflets together.
  • This heart valve therapy hardware may have been placed using surgical, transcatheter, or minimally- invasive means.
  • the hardware or therapy targeted for removal may be the MitraClip (Abbott Structural, Santa Clara, CA), the PASCAL device (Edwards Lifesciences, Irvine, CA), a suture placed surgically (e.g., Alfieri stitch), or similar heart valve therapy.
  • Other heart valve therapy may be the result of techniques that have involved the leaflets as part of a therapeutic target, and the part or whole leaflet involvement requires removal.
  • chordal replacement technologies placed with either transcatheter methods or surgery to compensate for improper length, disruption, or mispositioning of existing chords.
  • heart valve therapy shall be defined as any devices and/or methods used for therapeutic treatment of a heart valve, such as leaflet clips, sutures, artificial chords, or any other devices or methods associated with the treatment of heart valves and associated leaflets.
  • FIG 2 illustrates an example transcatheter delivery procedure for a valve clip 40 (e.g., a MitraClip) to treat a regurgitating mitral valve 20.
  • a delivery catheter 41 is advanced through the right atrium 16, through the atrial septum 18, and into the left atrium 12.
  • an inner portion of the catheter 41 A including a valve clip 40 is advanced through the mitral valve 20 and into the left ventricle 14.
  • the leaflet clip 40 includes two outer arms 40A positioned underneath the leaflets 22, 24, and two inner arms 40B positioned vertically between the two leaflets 22, 24.
  • the catheter 41 includes control wires that can cause the outer arms 40A to close against the inner arms 40B to pinch or engage the tissue of the leaflets.
  • the leaflet clip 40 helps the leaflet clip 40 to anchor within the tissue of the leaflets 22, 24, as seen in Figure 4.
  • the catheter 41 is removed, as seen in Figure 5.
  • the leaflet clip 40 is typically positioned near a center of the valve 20, preventing the center portion from opening and creating two smaller valve openings on either side of the clip 40. The smaller diameter of these openings typically allows the leaflets to better coapt and prevent regurgitation.
  • these structures need to be removed in order to facilitate other valvular therapy, such as when there is recurrent or residual regurgitation that needs to be addressed.
  • the valve may require placement of other leaflet technologies, annuloplasty or rings, chordae or cords, positioning devices, or a replacement valve, many of which may not be usable with heart valve therapy previously performed.
  • these therapies need to be removed from one or more attachment points on the leaflets, but not completely in order to facilitate other valvular therapy, leaving the structure in the heart but able to move it from the area of interest and apply desired therapy.
  • the present disclosure relates to systems and methods for removing heart valve therapies that have been used to position valve leaflets. This removal may be necessary when additional therapies for the treatment of valve disease are needed (e.g., different repair method, valve replacement), when the heart valve therapies have caused harm or the potential for harm to a patient (e.g., stenosis, infection), when the heart valve therapies have been deemed to not be of clinical benefit, or when there is a general desire to not have the therapy in place.
  • additional therapies for the treatment of valve disease are needed (e.g., different repair method, valve replacement)
  • the heart valve therapies have caused harm or the potential for harm to a patient (e.g., stenosis, infection)
  • the heart valve therapies have been deemed to not be of clinical benefit, or when there is a general desire to not have the therapy in place.
  • the present disclosure relates to systems and methods for removing heart valve therapies used to position leaflets, and this heart valve therapy may have been placed using surgical, transcatheter, or minimally-invasive means.
  • the hardware or therapy targeted for removal may be the MitraClip (Abbott Structural, Santa Clara, CA), the PASCAL device (Edwards Lifesciences, Irvine, CA), a suture placed surgically (e.g., Alfieri stitch), or similar positioning devices and techniques.
  • such positioning devices that need to be removed may be the result of techniques that have involved the leaflets as part of a therapeutic target, and the part or whole leaflet involvement requires removal. Examples of such devices are chordal replacement technologies placed with either transcatheter methods or surgery. In some instances, the cord or chords are not effective due to improper length, disruption, mispositioning, or defective prosthetic material.
  • a present method comprises a tool for cutting native valve tissue that has been attached to heart valve therapy with or without a capturing tool to hold the hardware to be removed while it is exteriorized from the human body.
  • the cutting method consists of an adjustable snare that envelops the heart valve therapy and can either cut the native tissue from the heart valve therapy mechanically, or by using a RF electrosurgical device that will heat tissue such that the electrosurgical cutting device’s intracellular temperature rapidly reaches 100 degrees C, the intracellular contents undergo a liquid to gas conversion, massive volumetric expansion, and resulting vaporization.
  • the capturing tool is an adjustable basket, bag, or bin. This capturing tool can be used to cut, release, compress, modify, or fully retrieve the heart valve therapy from the human body.
  • a method for removing previously placed heart valve therapy consists of a steerable catheter, which has been inserted into the patient using a transseptal, transatrial, or transventricular approach.
  • the steerable catheter contains a delivery catheter that enables placement of the tools for cutting and for capturing the heart valve therapy.
  • capture of the heart valve therapy is performed by insertion and embedding of a tool directly into, onto, and/or around the heart valve therapy.
  • the native tissue is cut from the heart valve therapy by the use of an electrosurgical cutting device (RF electrical or a similar device) or similar energy or force delivered from within the embedded tool.
  • RF electrical or a similar device electrosurgical cutting device
  • a basket or bag to capture the heart valve therapy may not be necessary for removal of the targeted material.
  • a cutting tool is used alone without the need for a capturing basket.
  • a loop structure is pushed onto the tissue bridge, chordal implants, or method of fixation created by the heart valve therapy.
  • the loop structure can be used to cut with either electrification or mechanical means.
  • the loop structure may be circular, oval, or multi-segmented, and may completely or incompletely encapsulate the area for cutting and removal.
  • the loop structure can be used to encircle the heart valve therapy and tissue for removal, followed by exteriorization.
  • a tool is used to expand the heart valve therapy for removal.
  • This expansion can be mechanical, electrical, pneumatic, hydraulic, or similar means in order to unfold or change the shape of heart valve therapy for its removal.
  • Elements of the tool can be fixated to the heart valve therapy to reduce the risk of embolization. This fixation can be accomplished by anchors that are straight, helical, barbed, or a combination of these approaches.
  • a catheter, spacer, balloon, or other device could be used in conjunction with the removal device to manage the blood flow or regurgitation of the valve post removal of the heart valve therapy. This could be performed quickly if the removed heart valve therapy and basket could be retracted through the steerable catheter- then this sealing device could be delivered through the same delivery catheter.
  • a further embodiment of the present invention is directed to a removal system for a valve clip or similar heart valve therapy that may include a cutting and capture catheter and a snare catheter, both of which can be deployed from the same or separate delivery catheters.
  • the snare catheter can be used to initially grasp and pull the valve clip distally (e.g., further into the left ventricle) to create tension or force on the leaflets.
  • the cutting loop and basket of the cutting and capture catheter can be placed over the valve clip so that the cutting loop is positioned on the proximal or atrial side of the heart valve therapy.
  • the cutting loop can be activated to cut off the heart valve therapy device, and finally the clip can be captured by the basket and removed from the patient.
  • This design enables cutting and capture of the heart valve therapy simultaneously as the cutting loop is pulled through the tissue and the capture basket is closed around the heart valve therapy device.
  • the snare catheter may include a snare loop having a circular shape or an oval saddle shape that creates an arc shape along each of its sides.
  • the snare loop may have a plurality of teeth, a frictional coating, or can be composed of a coiled wire.
  • the snare catheter may also include a distal tip with an opening in its sidewall and features to create friction with a snared valve clip, such as abrupt edges, ridges, grooves, or hooks.
  • the snare catheter may also include a handle configured to retract the snare loop into the snare catheter.
  • the handle may include a mechanism to ensure tension is always applied to the clip, as well as limit the amount of force the user can apply to the tightened snare.
  • the handle may include a locking mechanism to lock the snare in a desired retracted position.
  • the removal system may also include a guidewire passage through one or both of the cutting and capture catheter and a snare catheter.
  • a guidewire passage may extend through the snare catheter and the basket of the cutting and capture catheter. The guidewire could traverse the length of the capture basket or pass through only the tip and then alongside the exterior surface of the basket.
  • the removal system may also include a chord dilator configured to at least partially block a distal opening of the delivery catheter and provide a relatively smooth transition which may provide less abrupt surfaces to “catch” on a chord or other feature of the valve.
  • the cutting and capture catheter may also include a stretchable capture basket that stretches from a longitudinally compressed configuration to a longitudinally stretched configuration once a valve clip is captured.
  • the removal system may also include a catheter that is configured to push on a valve clip from the atrial side of the valve to provide counter force.
  • the cutting loop of the cutting and capture catheter may be better able to be positioned between the atrial side of the valve clip and the valve leaflets.
  • the catheter may be configured solely for contact or may be configured to affirmatively engage or attach the valve clip.
  • the removal system may also include a snare catheter that includes a cutting element that allows it to engage tissue surrounding a valve clip or other heart valve therapy to facilitate capture and removal.
  • Figure 1 illustrates the anatomy of a heart.
  • Figure 2 illustrates a side view of a procedure to implant a leaflet heart valve therapy device.
  • Figure 3 illustrates a side view of a procedure to implant a leaflet heart valve therapy device.
  • Figure 4 illustrates a side view of a procedure to implant a leaflet heart valve therapy device.
  • Figure 5 illustrates a side view of a procedure to implant a leaflet heart valve therapy device.
  • Figure 6 illustrates a top view of a procedure to implant a leaflet heart valve therapy device.
  • Figure 7 illustrates a side view of a removal catheter according to the present invention.
  • Figure 8 illustrates a side view of a removal catheter according to the present invention.
  • Figure 9 illustrates a side view of a removal catheter according to the present invention.
  • Figure 10 illustrates a side perspective view of a removal catheter according to the present invention.
  • Figure 11 illustrates a side view of a removal catheter according to the present invention.
  • Figure 12 illustrates a cross-sectional view of a removal catheter according to the present invention.
  • Figure 13 illustrates an exploded view of a removal catheter according to the present invention.
  • Figure 14 illustrates a perspective view of a cutting loop according to the present invention.
  • Figure 15 illustrates a perspective view of a cutting loop according to the present invention.
  • Figure 16 illustrates a perspective view of a cutting loop according to the present invention.
  • Figure 17 illustrates a perspective view of a cutting loop according to the present invention.
  • Figure 18 illustrates a perspective view of a cutting loop according to the present invention.
  • Figure 19 illustrates a perspective view of a cutting loop according to the present invention.
  • Figure 20 illustrates a top view of a cutting loop according to the present invention.
  • Figure 21 illustrates a top view of a cutting loop according to the present invention.
  • Figure 22 illustrates a perspective view of a cutting loop according to the present invention.
  • Figure 23 illustrates a cross-sectional view of a cutting loop according to the present invention.
  • Figure 24 illustrates a cross-sectional view of a cutting loop according to the present invention.
  • Figure 25 illustrates a cross-sectional view of a cutting loop according to the present invention.
  • Figure 26 illustrates a cross-sectional view of a cutting loop according to the present invention.
  • Figure 27 illustrates a cross-sectional view of a cutting loop according to the present invention.
  • Figure 28 illustrates a cross-sectional view of a cutting loop according to the present invention.
  • Figure 29 illustrates a cross-sectional view of a cutting loop according to the present invention.
  • Figure 30 illustrates a cross-sectional view of a cutting loop according to the present invention.
  • Figure 31 illustrates a side view of a basket according to the present invention.
  • Figure 32 illustrates a side view of a basket according to the present invention.
  • Figure 33 illustrates a side view of a removal catheter according to the present invention.
  • Figure 34 illustrates a side perspective view of a removal catheter according to the present invention.
  • Figure 35 illustrates a side perspective view of a removal catheter according to the present invention.
  • Figure 36 illustrates a side perspective view of a removal catheter according to the present invention.
  • Figure 37 illustrates a side view of a removal catheter according to the present invention.
  • Figure 37 illustrates a side view of a removal catheter according to the present invention.
  • Figure 39 illustrates a side view of a removal catheter according to the present invention.
  • Figure 40 illustrates a side view of a basket according to the present invention.
  • Figure 41 illustrates a side view of a basket according to the present invention.
  • Figure 42 illustrates a side view of a basket according to the present invention.
  • Figure 43 illustrates a side view of a basket according to the present invention.
  • Figure 44 illustrates a side view of a handle according to the present invention.
  • Figure 45 illustrates a side view of a handle according to the present invention.
  • Figure 46 illustrates a side view of a removal catheter according to the present invention.
  • Figure 47 illustrates a side view of a removal catheter according to the present invention.
  • Figure 48 illustrates a side view of a removal catheter according to the present invention.
  • Figure 49 illustrates a side view of a removal catheter according to the present invention.
  • Figure 50 illustrates a side view of a removal catheter according to the present invention.
  • Figure 51 illustrates a side view of a removal catheter according to the present invention.
  • Figure 52 illustrates a side view of a removal catheter according to the present invention.
  • Figure 53 illustrates a side view of a removal catheter according to the present invention.
  • Figure 54 illustrates a side view of a removal catheter and guide catheters according to the present invention.
  • Figure 55 illustrates a side view of a removal catheter and guide catheters according to the present invention.
  • Figure 56 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 57 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 58 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 59 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 60 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 61 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 62 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 63 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 64 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 65 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 66 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 67 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 68 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 69 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 70 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 71 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 72 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 73 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 74 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 75 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 76 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 77 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 78 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 79 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 80 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 81 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 82 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 83 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 84 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 85 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 86 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 87 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 88 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 89 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 90 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 91 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 92 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 93 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 94 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 95 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 96 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 97 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 98 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 99 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 100 illustrates a side view of a removal catheter procedure according to the present invention.
  • Figure 101 illustrates a perspective view of a removal catheter apparatus according to the present invention.
  • Figure 102 illustrates a perspective view of a removal catheter apparatus according to the present invention.
  • Figure 103 illustrates a perspective view of a removal catheter apparatus according to the present invention.
  • Figure 104 illustrates a perspective view of a removal catheter apparatus according to the present invention.
  • Figure 105 illustrates a perspective view of a removal catheter apparatus according to the present invention.
  • Figure 106 illustrates a perspective view of a removal catheter apparatus according to the present invention.
  • Figure 107 illustrates a perspective view of example cuts to a valve.
  • Figure 108 illustrates a perspective view of a removal catheter apparatus according to the present invention.
  • Figure 109 illustrates a perspective view of a removal catheter apparatus according to the present invention.
  • Figures 110 and 111 illustrate views of a snare and removal system according to the present invention.
  • Figures 112 and 113 illustrate views of a basket tip according to the present invention.
  • Figures 114 and 115 illustrate views of a snare loop according to the present invention.
  • Figure 116 illustrates a snare loop according to the present invention.
  • Figure 117 illustrates a snare loop according to the present invention.
  • Figure 118 illustrates a portion of a snare loop according to the present invention.
  • Figure 119 illustrates a portion of a snare loop according to the present invention.
  • Figures 120 and 121 illustrate a snare catheter tip according to the present invention.
  • Figure 122 illustrates a snare catheter tip according to the present invention.
  • Figure 123 illustrates a snare catheter tip according to the present invention.
  • Figure 124 illustrates a snare catheter tip according to the present invention.
  • Figures 125 and 126 illustrate a handle for a snare catheter according to the present invention.
  • Figures 127, 128, 129, and 130 illustrate a method of snaring and removing a valve clip according to the present invention.
  • Figures 131 , 132, and 133 illustrate a removal system configured for access via a guidewire.
  • Figures 134, 135, 136, and 137 illustrate a chord dilator according to the present invention.
  • Figure 138A illustrates a removal system with an alternate guidewire path.
  • Figure 138B illustrates a removal system with an alternate guidewire path.
  • Figure 139 illustrates a removal system with a pigtail wire on a distal end of its basket according to the present invention.
  • Figures 140 and 141 illustrate a stretchable basket according to the present invention.
  • Figure 142 illustrates a method of applying force to a valve clip according to the present invention.
  • Figure 143A illustrates an alternate basket shape according to the present invention.
  • Figure 143B illustrates an alternate basket shape according to the present invention.
  • Figure 144 illustrates an alternate removal system without a basket according to the present invention.
  • Figure 145 illustrates an alternative removal system with a cutting element as part of the snare loop according to the present invention.
  • Figure 146 illustrates an alternative removal system with a cutting element as part of the snare loop according to the present invention.
  • the present invention is generally directed to devices and methods for removing heart valve therapy devices via a transcatheter procedure. While current methods for removal of heart valve therapy devices require open heart surgery, the techniques and devices of the present invention utilize transcatheter devices and procedures which are less invasive and can provide better patient outcomes.
  • heart valve therapy shall be defined as any devices and/or methods used for therapeutic treatment of a heart valve, such as leaflet clips, sutures, artificial chords, or any other devices or methods associated with the treatment of heart valves and associated leaflets. While specific embodiments may discuss or illustrate specific heart valve therapy devices or methods, such as heart valve leaflet clips, it should be understood that use with any heart valve therapy is specifically contemplated. Hence, none of the embodiments discussed in this specification should be limited solely to use with heart valve leaflet clips.
  • FIGs 1-13 illustrate various aspects of one embodiment of a removal catheter 100 for removing a leaflet heart valve therapy device, such as a valve clip 40 or similar heart valve therapy device, according to the present invention.
  • the removal catheter 100 generally includes an expandable capture basket 102 and a cutting element or cutting loop 104 that is disposed near a top opening of the basket 102.
  • the basket 102 is placed over an implanted valve clip 40 so that a top of the basket 102 and the cutting loop 104 are positioned between the clip 40 and the leaflets 22, 24 on the leaflets 22, 24 atrial side.
  • the top opening of the basket 102 is closed or decreased in diameter and the cutting loop 104 is activated to cut the leaflet tissue surrounding the valve clip 40 (e.g., supplying radio frequency energy), freeing the clip 40 from the valve 20.
  • the capture basket 102 containing the valve clip 40 is retracted and removed from the patient. Further details and variations of the removal catheter 100 are discussed below, followed by example approaches and methods of removal for various heart valves (e.g., a mitral valve 20 or a tricuspid valve 15).
  • the removal catheter 100 includes an inner control member 108 (seen best in Fig. 11 ) that is positioned within an outer tubular sheath 110.
  • the inner control member 108 can be a solid wire or tube that extends between a distal end and a proximal end of the sheath 110.
  • the basket 102 and cutting loop 104 are connected to a distal end of the inner control member 108 such that when the inner control member 108 is longitudinally or rotationally moved relative to outer tubular sheath 110, the basket 102 and cutting loop 104 are similarly moved.
  • a plurality of loops 102A are positioned around the circumference of the top opening of the basket 102 and a wire or cinching loop 106 is disposed through the loops 102A.
  • the cinching loop 106 can be composed of a loop shaped wire (e.g., circular, oval, etc.) and an elongated straight portion 106A that that can be connected to the control member 108 via a connecting sleeve 112.
  • the connecting sleeve 112 can be clamped, welded, applied with adhesive/epoxy, or any combination of the same to affix the sleeve 112 to the control member 108.
  • the cinching loop 106 can be connected to the control member 108 only via welding or adhesive.
  • the cutting loop 104 can similarly be formed in a general loop shape (e.g., circular, oval, saddle shape, etc.) and can include an elongated straight portion 104E that can also be connected to the control member 108 via the connecting sleeve 112. In this respect, both of the elongated straight portions 106A and 104E are located within the connective sleeve 112, as seen in the cross-sectional view of Figure 12.
  • the cutting loop 104 cuts tissue when radio frequency energy is supplied to it.
  • the RF power source is connected to a proximal end of the control member 108 which is composed of a conductive metal and therefore communicates the RF energy to its distal end and then into the attached cutting loop 104.
  • a second RF electrode can be connected to the RF power source and can be attached elsewhere to the patient via an electrode pad (a monopolar RF system), a second electrode can be included elsewhere on the removal catheter 100 (a bipolar RF system), or a second insulated wire can be included on the control member 108 (a bipolar RF system).
  • the cutting loop 104 can have different structures, shapes, and electrical insulation to help reduce the risk of an uninsulated portion 104B (i.e., the portion that cuts the leaflet tissue) from contacting any portion of the cinching wire 106 or basket 102.
  • Figure 14 illustrates a cutting loop 104 in which the uninsulated portion 104B of the wire is located opposite of the elongated straight portion 104E, adjacent to insulated portions 104A on each side.
  • the uninsulated portion 104B can extend entirely around the circumference of the wire as seen in Figure 21 or can only be exposed along the interior side of the loop 104 as seen in Figure 20.
  • the uninsulated portion 104B may include only a single area in which the underlying wire 104C is exposed (e.g., between about 1 and 5 mm) as seen in Figure 14 or can include a plurality of discrete uninsulated portions 104B (e.g. , 2-10 portions 104B) of a relatively smaller length (e.g. between about land 5 mm) as seen in Figure 22.
  • the majority of the surface of the cutting loop 104 is insulated.
  • the cutting loop insulation 104A can be selectively removed (for wires with existing insulation) to expose the cutting loop conduction wire 104C in a manner that will allow it to contact and deliver the RF cutting energy to the leaflet tissue bridge when it is in contact with tissue in proximity to the heart valve therapy .
  • the insulation 104A can be added (e.g., by dipping, spraying, or similar techniques) and the uninsulated portions 104B can be created by masking the intended areas prior to insulation application.
  • the uninsulated portion 104B can be oriented any number of ways, e.g., on the inner/outer surface of the cutting loop 104 as well as on the bottom (i.e., atrial) side of the loop 104.
  • the underlying wire 104C of the cutting loop 104 may be composed of a shape memory metal (e.g., Nitinol) or a similar conductive metal (e.g., stainless steel or copper). As seen in the cross-sectional views of Figures 23, 24, and 25, the underlying wire 104C can have a rectangular cross section, a circular cross section, a triangular cross section, and a square cross section, respectively.
  • a shape memory metal e.g., Nitinol
  • a similar conductive metal e.g., stainless steel or copper
  • the cutting loop 104 may also be composed of one or more wires, such as a first wire 104C and a second wire 104D. Both wires can be composed of similar material (e.g., Nitinol, stainless steel, copper, silver, or similar materials), or each wire can be composed of a different material.
  • one wire 104C can be composed of a metal that better conducts current (e.g., stainless steel, silver, or copper) and the other wires 104D can be composed of a material that retains its shape between a compressed and expanded configuration (e.g., shape memory metal such as Nitinol).
  • the multiple wires may be electrically isolated or insulated from each other or independently. Different cross sectional shapes can be further used with the same or different materials, as seen in Figures 16-18 and 26-28.
  • the cutting loop 104 may be composed of a single wire containing a plurality of strands of different wire materials.
  • Figures 19 and 29 illustrate a wire core 104D composed of a shape memory strand with a plurality of conductive strands 104C are located circumferentially around the core 104D.
  • Figure 30 includes alternating shape memory strands 104D and conductive strands 104C.
  • the different strands may provide both desirable current conduction and the ability to expand to a predetermined loop shape from a compressed configuration.
  • the multiple wires may be electrically isolated or insulated from each other or independently. Either of these two cable examples can have 2-49 or more strands within them.
  • the cutting loop may have a variety of different shapes, structures, and electrical insulation patterns to facilitate tissue removal around the clip 104 that can, for example, provide additional length and/or a predetermined path or geometry.
  • Figure 101 illustrates one alternate example of a cutting loop 316 having a “saddle” or wave shape in which each side portion 314, 315 of the loop dips downward (i.e., in a proximal direction toward the catheter 100) and its free end 311 bends upwards (i.e., in a distal direction away from the catheter 100).
  • Side portions 314 and 315 can be insulated and middle portion 311 and end portions 312 and 313 can be insulated.
  • the middle portion 311 contacts or engages the tissue on one side of the loop 316, while end portions 312 and 313 contact or engage the tissue on the other side.
  • the side portions 315 and 316 can bend outwards to increase the width of the loop 316, inwards to decrease the width of the loop 316, or can be relatively straight to maintain a uniform width of the loop 316 (i.e., circular or elliptical in shape).
  • end portions 312 and 313 can be electrically activated first in unison while the cutting loop 316 applies axial tension onto the tissue structure, effectively cutting the tissue in contact with those portions 312, 313 and partially freeing the leaflet clip 40.
  • the free end portion 311 can be activated to excise the tissue adjunct to it and completing the excision of the leaflet clip 40 from the leaflets.
  • all three portions 311 , 312, and 313 can be activated at the same time.
  • Axial tension on the loop 316 can be applied before, during, or intermittently to control the engagement of the loop 316.
  • This embodiment illustrates three uninsulated cutting areas or portions 311 , 312, and 313, however there may be any number of cutting elements (e.g., from 1 -100), including the entire loop 316 as being one continuous, uninsulated cutting member.
  • Including additional length along the side portions 314 and 315 can accommodate other tissue structures present around the leaflet clip 40.
  • the extra length of the side portions 314 and 315 can also be deformable such that when tension is applied by the elongated straight portions 317, the side portions 314 and 315 will straighten and cause the loop 316 to elongated to an approximate axial configuration.
  • the axial distance between the free end portion 311 and the proximal end portions 312, 313 is increased, accommodating a greater variation in both diameter and approach angle to the clip. Any such nonlinear path could also accomplish this and are hence considered in this disclosure, but for sake of brevity are not shown herein.
  • Figure 102 illustrates a delivery mechanism with a previously described cutting loop 316 and an outer tubular sheath 320 that is generally similar to that of previously described sheath 110.
  • the outer tubular sheath 320 further includes a sheath cutting portion 321 that is disposed at and circumferentially around the distal end of the sheath 320.
  • This sheath cutting portion 321 can be of similar construction and characteristics as previously described uninsulated portions of the prior cutting loops and can be similarly electrically activated to provide facilitate additional areas of tissue that can be cut.
  • This outer tubular sheath 320 can be used in conjunction with any of the other apparatuses disclosed and in a method that best facilitates the leaflet clip removal procedure. Again, all of the uninsulated cutting portions 311 , 312, 313, and 321 can be activated individually at different times or all together at the same time.
  • Figure 103 illustrates the embodiment of Figure 102 within a heart valve tissue model 330, with chordae 13 and a leaflet positioning clip 40. This figure illustrates one example of how the apparatuses 320 and 316 engage tissue on all sides of the clip 40 in a manner that is positioned to sever the attaching tissue structures from the clip apparatus 40.
  • FIG. 104 Another example embodiment of a cutting loop 350 can be seen in Figure 104, in which each side loop portion 314, 315 bends upward (i.e., in a distal direction) and its free end bends downward (i.e., in a proximal direction). Additionally, the side loop portions 314, 315 are shown bending laterally outward, increasing the width of the loop 350.
  • the loop 350 can have a variety of different insulated and uninsulated portions, such as those described in Figures 101-103 (i.e., several discrete uninsulated portions or the entire loop being uninsulated).
  • Figures 105 and 106 illustrate another embodiment of a removal device 360 that is generally similar to the removal device 100 but further includes a first cutting loop 104 and a second cutting loop 316.
  • a first series of cuts to the valve tissue and then one or more second cuts (e.g., via cinching the first cutting loop) to completely remove the heart therapy without the need for dramatic repositioning of the loops.
  • a single cutting loop may need to be moved, longitudinally repositioned, and/or rotated to fully cut out the heart therapy.
  • the first cutting loop 104 has a somewhat larger diameter (e.g., similar to the opening of the basket 104) and the second cutting loop 316 has a diameter that is smaller than the first cutting loop 104 and that is positioned further away from the basket 104.
  • the second loop 316 may be placed against the valve leaflets and/or chords (e.g., cut 370A through the antero-lateral chords and cut 370B through the postero-medial chords in Fig. 107) and the cutting portions 311 , 313, and 313 can be activated to perform the first series of cuts to the tissue.
  • This first series of cuts may not cut all of the tissue, however the cutting portion 104B of first cutting loop 104 can cinched and then activated to perform one or more second cuts to completely remove any remaining tissue from the heart therapy device 40 (e.g., along cut 370C on the atrial side of the clip 40 in Fig. 107).
  • Figure 108 illustrates an embodiment 180 with two loops 316 of similar shape and configuration.
  • either of the loops may have different numbers and patterns of cutting portions and may activate those cutting portions all simultaneously or at different times/patterns.
  • both of the cutting loops 104 and 316 are connected to the same electrical circuit (e.g., the inner control member 108).
  • each loop 104, 316 (or alternately each set of cutting portions) may have its own electrical circuit (e.g., individual conducting wires) that allows for independent activation from the other cutting loop.
  • three or four cutting loops may alternately be used.
  • the cutting loops may all be connected to the same removal catheter or one or more loops can be connected to a catheter separate from other cutting loops and/or the basket 104.
  • one or more cutting loops may be located on the ventricular side of the valve while one or more cutting loops may be located on the atrial side of the valve.
  • the cutting loop 104 may be located directly on top of the cinching loop 106, contacting the loop.
  • the cutting loop 104 may also be longitudinally spaced apart from the cinching loop 106, such as between about 0 mm and about 15 mm.
  • the inner control member 108 (seen best in Figures 11-13) is flexible enough to navigate through the vasculature while having enough column strength to push the basket 102 and cutting loop 104 out of the outer tubular sheath 110, be capable of efficiently delivering RF energy from the proximal handle to the cutting loop, be insulated to prevent current leakage to the bloodstream, and have good torque response so the user can rotate the basket and loop when it is deployed in and around the valve.
  • the inner control member 108 consists of an inner control stylet that is joined or welded to a more flexible inner control cable, which is then joined to the cutting loop conduction wire tails using a distal coupler, in a preferred embodiment the inner control stylet, inner control cable, cutting loop conduction wire, and distal coupler are the same material (e.g., steel alloy) to enable a strong weld joint and efficient current delivery throughout.
  • the inner control cable could be a laser cut tube, a stranded cable, a stranded cable tube, a coil, or a combination of these.
  • the inner control cable may extend from the proximal handle to the cutting loop 104, and eliminate the need for the inner control stylet.
  • the inner control member 108 can be two separate wires; one of which connects to the cinching loop 106 and the other that connects to the cutting loop 104.
  • the basket 102 may be deployed first by advancing the inner basket control member distally until the basket cinching loop 106 is fully exposed. Then, the inner cutting loop control member can be advanced distally to deploy the cutting loop 104.
  • Each of the loops can be rotated, advanced, or retracted by their respective control members. This provides the operator with more degrees of freedom.
  • the heart valve therapy may be first captured or encircled by the cutting loop 104, and then the basket cinching loop 106 and basket 102 can follow.
  • the cutting loop 104 can then be closed onto the leaflet tissue bridge by retracting the inner cutting loop control member. Once the cutting loop is closed on the tissue bridge, one of two steps can be taken: 1 ) the basket cinching wire 104 and basket 102 can then be closed by retracting the inner basket control member proximally or 2) if the cutting loop 104 is unable to get to the base of the heart valve therapy, RF cutting energy can be applied to cut down one side of the device to get to the base of the clip 40; then the basket 102 can be closed.
  • the inner cutting loop control member is energized with RF power as it is retracted proximally into the outer delivery sheath 110.
  • the inner cutting loop control member delivers the cutting energy to only the cutting element through the cutting loop 104.
  • the aforementioned inner control members can alternately be disposed in separate outer tubular sheaths or separate lumens in the same sheath 110. It is possible for this system to be designed such that each sheath can be placed in separate orifices (i.e., on opposite sides of the heart valve therapy). Once both loops have captured the heart valve therapy, the same steps as described above would follow.
  • control member insulation that covers the outer surface of the inner control stylet and inner control member is preferred to be flexible enough to not impact the navigation of the delivery catheter through a valve orifice. It is also desirable be as lubricious as possible, such that the friction between the inner control member and the delivery catheter is minimized as the inner control member is pushed distally to deploy the basket and cutting loop in the left ventricle.
  • this insulation may include a hydrophilic coating, a silicone coating, a Teflon like coating, a polyolefin coating, a thermoform or thermoset coating, or fluoropolymers.
  • the length and diameter of the basket 102 may depend on the size of the heart valve therapy device or clip 40.
  • the basket 102 may have a length within a range of about 20 mm to about 50 mm, and a diameter within a range of about 10 mm and 20 mm.
  • the diameter of the basket 102 can be adjusted accordingly. For example, the greater the angle of interception relative to a top plane across the opening of the basket 102, the larger the diameter of the basket 102 should be. Put another way, unless it is expected that the basket 102 is to be substantially directly underneath the clip 40, the basket 102 should expand to a diameter much greater than that of the clip 40.
  • the basket 102 can be composed of a plurality of braided wires.
  • the wires can be composed of a shape memory material and can be braided on a mandrel of a desired basket size, then heat set so that the braided shape returns to the expanded basket configuration after being compressed.
  • the wires can be composed of a shape memory material such as Nitinol or a nonshape memory material such as stainless steel.
  • the wires may also have an insulating coating such as ETFE, polyimide, parylene, silicone, or similar materials.
  • the benefits of a woven basket are that its behavior/performance can be altered by changing the basket wire diameter, basket wire material, and/or weave density (i.e., basket pore size) while keeping the diameter and length of the basket fixed.
  • the basket diameter and length design are primarily driven by the size of the intended heart valve therapy to be removed.
  • the size, spacing, and number of woven basket eyelets could also be adjusted and optimized.
  • the pores 102B of the basket 102 when expanded are within a range of about 100 microns to about 4 mm in diameter.
  • the wire size is preferably small enough to allow for it to be easily collapsed into and deployed from the delivery catheter during the procedure, but large enough to give the basket some rigidity such that it can adequately open in the presence of valve chordae or other structures.
  • the basket pore size can vary on a woven basket, depending on the design intent. In general, the pore size should be smaller than either the length, width, or height of the heart valve therapy to avoid it embolizing through the basket after it has been cut free. Weaving a basket with very small pores could help with filtering and capturing any debris generated during the tissue cutting process.
  • One benefit of coating a metal basket is to ensure the electrical energy is concentrated in the cutting element and not being distributed across the entire metal structure of the basket and into the blood pool.
  • the second benefit of coating is that it can also reduce friction and therefore can facilitate easier capture of the heart valve therapy inside the basket. If the basket is too rough or there are too many edges inside the basket, the heart valve therapy may not want to fully seat within the basket. Adding a lubricious coating or a smooth layer to the inner surface of the capture basket may enable easier capture of the heart valve therapy .
  • a removal catheter 150 includes a basket 152 composed of a polymer such as silicone, PET, polyester, nylon, polypropylene, Kevlar, or a similar material that can fold or pleat to a radially compressed configuration.
  • the basket 152 may be formed with a plurality of apertures that are sized to prevent passage of both the leaflet clip 40 and other biological material that may break off from the procedure (e.g., about 100 microns to about 4 mm in diameter).
  • the basket 152 can be of similar size to the previously discussed basket 102.
  • the top opening of the basket 152 may also include a plurality of loops or passages 152B sized to allow passage of the cinching loop 106 so that the basket 152 can be closed during a procedure.
  • Construction of the polymer basket 152 can be completed using a braid, mesh, weave, knit, or via injection molding. Potential basket shape and material combinations are infinite, and only a few are described here. Choosing a polymer material that has high heat resistance, low moisture absorption, and is durable enough to be collapsed into the outer sheath multiple times is important. Silicone tends to meet all of these performance requirements the best. In the event the basket is made of a silicone, it could be molded into the basket shape as a standalone component, or molded directly onto a loop structure. If creating the basket from a flat sheet of silicone, it could be cut to a designed pattern, and stitched onto a loop, into the desired shape.
  • the size and spacing of the pores 152A can be adjusted, depending on the material selected. In general, the pore size may be smaller than either the length, width, or height of the heart valve therapy to avoid it embolizing through the basket after it has been cut free. Using a basket with very small pores may help with filtering and capturing any debris generated during the tissue cutting process. Designing a basket with pores also allows some blood to flow through it; this helps improve the operators control of the basket by minimizing the force applied to it from pumping blood (i.e. , it minimizes the ‘parachute effect’).
  • a polymer basket could be constructed with eyelets or not; if there are eyelets as shown, it will be slidably mounted to the basket cinching loop. If there are no eyelets, it will be securely affixed to the basket cinching loop.
  • the polymer basket 152 does not conduct current, other embodiments are possible in which the cutting loop 104 of a removal catheter 160 also acts as a cinching loop, as seen in Figures 35 and 36.
  • the basket 152 may be directly attached to the insulation portions 104A of the cutting loop 104 (or alternately may directly form the insulation portions around the uninsulated wire), leaving open the exposed, uninsulated portion 104B that performs the leaflet cutting.
  • Figure 37 illustrates a plurality of polymer or fabric filaments braided together to form a flexible basket shape and relatively large apertures (e.g., about 0.5 mm to about 4 mm).
  • Figure 38 illustrates a plurality of polymer or fabric fibers woven into a fabric basket 164 with relatively smaller apertures (e.g., about 0.5 mm to about 4 mm).
  • Figure 39 illustrates a polymer sheet that is stitched to form a basket 166.
  • the cutting loop 104 can be exposed so that the uninsulated portion 104B can cut through the valve leaflets after being cinched.
  • the basket can be partially or fully composed of a laser cut basket.
  • Figures 40 and 41 illustrate a plurality of vertical, laser cut ribs with eyelet disposed along their length to allow for a plurality of wires or polymer filaments to be braided or woven through.
  • Figures 42 and 43 illustrates laser cut basket shape that are entirely composed of a laser cut shape memory metal (e.g., a tube or sheet of shape memory metal).
  • the benefits of a laser cut basket are that its behavior/performance can be altered by changing the tube dimensions and/or cut pattern/density (i.e., basket pore size) while keeping the diameter and length of the basket fixed.
  • the basket diameter and length design are primarily driven by the size of the intended heart valve therapy to be removed.
  • the size, spacing, and number of laser-cut eyelets could also be adjusted and optimized.
  • the material used preferably has shape memory properties, like Nitinol, to allow for the laser cut portion of the tube to be expanded and shaped. Using a material with shape memory is what enables the basket to collapse and open back up to the same shape, repeatedly.
  • the wire size is preferably small enough to allow for it to be easily collapsed into and deployed from the delivery catheter during the procedure, but large enough to give the basket some rigidity such that it can adequately open in the presence of valve chordae or other structures.
  • Basket pore size can be varied in a laser cut design by changing the cut pattern to achieve the desired result.
  • pore sizes may vary within a range of about 100 microns to about 4 mm.
  • the pore size should be smaller than either the length, width, or height of the heart valve therapy to avoid it embolizing through the basket after it has been cut free.
  • One unique benefit of a laser cut basket is that the pore size and spacing could vary throughout the basket length. For example, the proximal opening side of the basket could have large pores with a certain pattern density. The pore size and pattern density could get smaller and denser towards the distal end of the basket.
  • any of the basket embodiments described in this specification can further include an outer covering to help collect any debris or embolic material freed during the procedure.
  • an outer covering may include a solid or perforated polymer sheet, a woven fabric, a tubular shape formed from relatively small, finely braided metal wires, or similar materials.
  • the interior of the basket can have a nonconductive liner, film, or coating (e.g., silicone) on its inner surface to help prevent conduction with the cutting element 104.
  • the removal catheter 100 can include a proximal handle portion 170, as seen in Figures 44 and 45.
  • the handle 170 includes an outer housing 172 and a sliding member 174 that is configured to slide within a longitudinal slot within the housing 172.
  • the housing 172 can be connected to the outer tubular sheath 110 while the sliding member 174 is connected to the inner control member 108, thereby allowing the user to adjust the position of the sliding member 174 with their thumb to make a corresponding longitudinal move of the inner control member 108, basket 102, and cutting loop 106.
  • the handle 170 may also include a fluid connection port 176 (e.g., a luer port) that is in communication with an interior of the interior passage of the outer tubular sheath 110 so that an electrically neutral solution (e.g., a dextrose solution) can be delivered to the area near the cutting loop, amplifying the tissue cutting effects and minimizing energy loss around the area to the blood pool.
  • an electrically neutral solution e.g., a dextrose solution
  • the amount and timing of this fluid can be determined by a physician (e.g., via a syringe) or via an electrically actuated pump mechanism based on a position of the cutting loop 106 (i.e., when the cutting loop is outside of the outer tubular sheath and in good contact with desired tissue 110).
  • the handle 170 may also include a locking mechanism 173 near a distal end of the housing 172 which locks the inner control member 108 in place relative to the outer tubular sheath 110.
  • the locking mechanism 173 can include a handle 177 that is configured to rotate a cam member 178 that surrounds a proximal end of the inner control member 108.
  • the cam member 178 creates an interference fit with the inside of the housing 172, locking the control member 108in its longitudinal position.
  • the handle 177 rotates the cam member 178 in the opposite direction, it releases the interference fit between the cam member 178 and the housing 172 to release the inner control member 108 so that it can longitudinally slide within the handle 170.
  • Figure 46 illustrates an embodiment of the removal catheter 100 with a current over-flow hole 111 in the outer tubular sheath 110.
  • This embodiment is most beneficial for an embodiment with a single cinch and cutting loop and either a polymer or minimally conductive basket 102.
  • the cutting element 104 and affixed basket 102 are retracted inside the outer tubular sheath 110 to begin cutting the leaflet tissue, the distal end of the outer tubular sheath 110 can become closed off from the blood pool. If this happens after the tissue has been cut, the current being delivered to the cutting element 104 is no longer being transferred to tissue or blood, and instead transfers the heat and/or electricity through the basket 102 and can damage it.
  • the current overflow hole 111 in the outer tubular sheath 110 can ensure the cutting element 104 is always in communication with the blood pool, even after the cut has been completed. In this way, the current will choose to flow through the blood to the opposite RF electrode attached elsewhere on the patient, as opposed to the basket.
  • a wire 113 can be attached to the inner control member 108 to ensure the current pathway always involves the blood pool, even after the cut has been completed.
  • the wire 113 is preferably designed to be long enough to always protrude from the distal end of the outer tubular sheath 110, even with the basket 102 fully collapsed inside the outer tubular sheath 110. It would also preferably have a very small region of exposed metal at the very distal tip, and the rest would be insulated. In this way, when the cut is completed the current will choose to flow through the lower resistance wire and to the blood as opposed through the higher resistance basket 102 (e.g., silicone).
  • FIGs 48-53 illustrate side views of the removal catheter 100 deploying and cinching its basket 102.
  • the basket 102, cinching loop 106, and cutting loop 104 are all located within the outer tubular sheath 110.
  • these components are radially compressed to a relatively smaller diameter to allow passage through the vessels of a patient (keeping them compressed in outer tubular sheath enables passage through smaller orifices and between multiple clips as well).
  • the inner control member 108 is distally advanced (e.g., via sliding member 174) so that the basket 102 begins to exit the outer tubular sheath 110 and radially expand. This distal movement continues until both the basket 102 and the cutting loop 104 have deployed and fully expanded outside the sheath 110, as seen in Figure 50.
  • Figures 51 and 52 illustrate the inner control wire 108 being retracted, causing both the cinching loop 106 and the cutting wire 104 to retract and radially close in diameter.
  • RF energy will be activated during this time so that as the cutting wire 104 closes, it cuts the tissue of the leaflets.
  • the RF current is deactivated.
  • the previously described sliding member 174 of the handle 170 may include a position switch that turns the RF energy on/off at a predetermined longitudinal position.
  • a manual on/off switch can be included on the handle 170 or RF power supply.
  • a radiopaque marker can be placed at the distal end of the outer tubular sheath 110.
  • the physician performs the tissue bridge cut, they will have their eyes on the fluoroscopy screen. Since tissue is typically not visible on fluoroscopy, providing the operator with a visual indicator on the catheter 100 indicating that the tissue bridge has been cut may be useful.
  • the inner control member 108 and cutting loop 104 are retracted into the sheath 110 during the cutting process and the radiopaque marker is located such that when the operator sees on fluoroscopy the entire cutting loop 104 on the proximal side of the radiopaque marker, the tissue bridge has been cut. Not only is this a useful visual indicator for the operator, but it also makes the procedure safer.
  • the RF cutting energy can be terminated immediately by the operator to prevent any unintended heating by applying power longer than necessary.
  • the opening of the basket 102 is nearly completely cinched closed and the positioned of the inner control member 108 may optionally be locked in place (e.g., with locking mechanism 173 on the handle 170).
  • the basket 102 may be maintained outside of the outer tubular sheath 110 and pulled into a larger guide catheter used during the procedure.
  • the present invention includes different methods or approaches of removing a heart valve therapy such as a valve clip 40.
  • Figures 56-61 illustrate a removal procedure in which the atrial septum 18 is crossed to access the mitral valve 20. While example access methods and procedures are described, it should be understood that variations are possible based on known catheter access techniques. Additionally, these access techniques can be used with any of the embodiments of this specification.
  • the mitral valve access procedure of Figures 56-61 may, in one embodiment, include an inner control member 108, an outer tubular sheath 110, an inner steerable catheter 180, and an outer transseptal guide catheter 182, which can be seen separately in Figure 54 and together in Figure 55 and are discussed further below.
  • the three nested but independent curving and axially articulating catheters make it possible to position the removal device anywhere in the heart regardless of size or procedural positioning.
  • other tools, sheaths, catheters, and similar devices may alternately be used to directed the removal catheter 100 as described below.
  • the left atrium 12 can be accessed by advancing a transseptal guidewire or needle to the atrial septum 18 (e.g., via the inferior vena cava 17 or the superior vena cava 19), using the guidewire to cross the atrial septum 18, and finally moving the guidewire into the left atrium.
  • a relatively larger diameter outer transseptal guide catheter 182 can be advanced over the guidewire and through the atrial septum 18 so the its distal end is located in the left atrium 12.
  • the transseptal guide catheter 182 can be advanced through the atrial septum 18 without the use of any transseptal guidewire.
  • the outer transseptal guide catheter 182 may optionally have a predetermined curve or bend that may help angle it from the inferior vena cava 17 towards the atrial septum 18.
  • the guidewire can be removed and the inner steerable guide catheter 180 can then be advanced through the outer transseptal guide catheter 182 so that its distal end is located within the left atrium 12.
  • the distal end of the inner steerable guide catheter 180 can be “steered” or deflected so that its distal opening is directed toward a desired location of the mitral valve 20. Since the guide catheter is independent of the outer transseptal guide catheter 182, the physician has the ability to direct the inner steerable guide catheter 180 to any location along the mitral valve 20, such that it can be rotated, advanced/retracted, or have the degrees of deflection altered while keeping the outer transseptal guide catheter 182 in the same location.
  • the inner steerable guide catheter 180 is preferably pointed towards either of the two valve openings on each side of the center clip 40 (see top view of Figure 6). Once pointed at the desired target location, the removal catheter 100 is advanced through the inner steerable guide catheter 180 and out its distal end, into the left atrium 12, through one of the side openings of the mitral valve 20, and into the left ventricle 14, as seen in Figure 56.
  • the inner control member 108 is distally advanced through the outer tubular sheath 110 of the removal catheter 100, causing the capture basket 102, cinching loop 106, and the cutting loop 104 to be advanced out of the outer tubular sheath 110.
  • the capture basket 102, cinching loop 106, and the cutting loop 104 are connected to the inner control member 108 so that they expand to an orientation in which the opening of the basket 102 and the opening of the cutting loop 104 are directed or point towards the leaflet clip 40.
  • the plane 103A of the opening of the basket 102 and the opening of the cutting loop 104 may be an angle 103C between 45 degrees and 135 degrees relative to an axis 103B of the inner control member 108 (e.g., 90 degrees).
  • the inner control member 108 can be rotated relative to the outer tubular sheath 110 (or alternately the entire removal catheter 100 can be rotated) to cause the capture basket 102, cinching loop 106, and the cutting loop 104 to also rotate within the left ventricle 14. In this manner, the physician can align or orient the basket 102 to a desired location directly beneath the leaflet clip 40.
  • the inner control member 108 (or alternately the outer tubular sheath 110) can be proximally withdrawn so that the leaflet clip 40 is positioned inside of the basket 102, as seen in Figure 59.
  • both the cutting loop 104 and the cinching loop 106 are positioned above the leaflet clip 40; that is between the leaflet clip 40 and the bottom adjacent surfaces of the leaflets 22 and 24.
  • the inner control member 108 is proximally retracted so as to partially retract the cinching loop 106 and the cutting loop 104. This causes the top opening of the basket 102 to close in diameter above the leaflet clip 40 and also causes the cutting loop 104 to reduce diameter and engage between an atrial side portion of the leaflets 22, 24 and the leaflet clip 40.
  • the outer transseptal guide catheter 182 has a large enough diameter to allow the basket 102 containing the leaflet clip 40 within it.
  • the removal catheter 100, inner steerable catheter 180, and outer transseptal guide catheter 182 can all be withdrawn from the patient as a single unit, if necessary.
  • an artificial valve may be installed at the location of the mitral valve 20. If a guidewire is used during the removal procedure, it can also be used to advance and orient a valve delivery catheter to delivery and implant the artificial valve.
  • a guidewire is used during the removal procedure, it can also be used to advance and orient a valve delivery catheter to delivery and implant the artificial valve.
  • One example of such an artificial valve replacement can be found in U.S. Pat. 8,579,964, entitled Transcatheter Mitral Valve Prosthesis, the content of which is hereby incorporated by reference.
  • a blood flow management apparatus such as a spacer, catheter, balloon, or other device is in and could be expanded in the location of the valve to manage the flow across the valve until such time as additional therapy could be delivered such as a replacement valve.
  • Figures 62-65 illustrate another method of removing a leaflet positioning device such as a leaflet clip 40 via a transapical approach.
  • a leaflet positioning device such as a leaflet clip 40
  • a transapical sheath 184 is advanced through the incision, through the apex of the heart 10, and into the left ventricle 14, as seen in Figure 62.
  • the removal catheter 100 is then advanced through the transapical sheath 184 so that a distal end of the outer tubular sheath 110 extends out into the left ventricle 14.
  • the inner control member 108 is distally advanced within the outer tubular sheath 110 so as to release and expand the basket 102 and cutting loop 104 into the left ventricle 14.
  • the cinching loop 106 and the cutting loop 104 preferably have a predetermined bend (e.g., a heat set bend/curve) that orients the top opening of the basket 102 and the opening of the cutting loops 104 towards the leaflet clip 40.
  • the plane of the top opening of the basket 102 and the opening of the cutting loops 104 can be within a range of 135 degrees to 225 decrees (e.g., about 180 degrees) relative to an axis of the inner control member 108.
  • the inner control member 108 can be further rotated (or the entire removal catheter 100 can be rotated) by the physician so as to best align the cutting loop 104 and basket 102 with the leaflet clip 40.
  • the outer tubular sheath 110 is further advanced out of the transapical sheath 184 so that the leaflet clip 40 is positioned completely within the basket 102.
  • the inner control member 108 is proximally retracted to cause the cinching loop 106 and the cutting loop 104 to decrease in diameter.
  • the top opening of the basket 102 decreases, trapping the leaflet clip 40 within it.
  • RF energy is activated and delivered to the loop 104, allowing the uninsulated portion 104B to cut through the leaflet tissue immediately above the leaflet clip 40.
  • the capture basket 102, cinching loop 106, and the cutting loop 104 are connected to the inner control member 108 so that they expand to an orientation in which the opening of the basket 102 and the opening of the cutting loop 104 are directed or point towards the leaflet clip 40.
  • the plane 103A of the opening of the basket 102 and the opening of the cutting loop 104 may be an angle 103C between 25 degrees and 135 degrees relative to an axis 103B of the inner control member 108 (e.g., 90 degrees).
  • the outer tubular sheath 110 can be proximally retracted and the basket 102 containing the leaflet clip 40 is withdrawn into the passage of the transapical sheath 184 for removal. If the basket 102 and leaflet clip 40 are too large for the transapical sheath 184, both the sheath 184 and the removal catheter 100 can be pulled out together simultaneously.
  • FIGs 66 and 67 illustrate another method of removing a heart valve therapy such as a leaflet clip 40 via a transaortic approach.
  • an aortic guide catheter 186 is first positioned into the aorta 11 and advanced into the left ventricle 14.
  • the aortic guide catheter 186 may have a fixed curve/shape that helps the physician direct the distal end of the catheter 186 beneath the leaflet clip 40.
  • the aortic guide catheter 186 may include steerable mechanisms to allow deflection in different directions.
  • the removal catheter 100 is advanced through the aortic guide catheter 186 so that a distal end of the outer tubular sheath 110 extends from the distal end of the catheter 186 and into the left ventricle 14.
  • the inner control member 108 is further distally advanced relative to the outer tubular sheath 110 so that the basket 102 and cutting loop 104 are deployed, expanded, and positioned in the left ventricle 14.
  • the opening of the basket 102 and the opening of the cutting loop 104 are both or oriented so that they face the leaflet clip 40.
  • the face of the opening of the basket 102 and the opening of the cutting loop 104 may be within a range of about 300 degrees and 45 degrees relative to an axis of the inner control member 108 (e.g., about 320 degrees).
  • the aortic guide catheter 186 is either moved or deflected (in the case of a steerable catheter) so that the cutting loop 104 and basket 102 are positioned over the leaflet clip 40.
  • the inner control member 108 is proximally retracted inside 110, causing the cinching loop 106 and the cutting loop 104 to decrease in diameter, closing the top opening of the basket 102.
  • RF energy is delivered to the loop 104, allowing the uninsulated portion 104 to cut areas of the leaflet tissue adjacent to the leaflet clip 40 and thereby freeing the leaflet clip 40 from the mitral valve 20.
  • the basket 102 and leaflet clip 40 can either be retracted through the aortic guide catheter 186 or all of the catheters can be removed together as a single unit simultaneously.
  • an outer tricuspid guide catheter 188 is first delivered to the right atrium 16 by either an approach through the inferior vena cava 17 or the superior vena cava 19.
  • the tricuspid guide catheter 188 may include a fixed curve at its distal end to help its distal opening towards the tricuspid valve 15 or can include steering mechanisms to perform the same.
  • An inner intermediate catheter 189 can then be advanced through the outer tricuspid guide catheter 188 to provide a better angle towards the tricuspid valve 15.
  • the inner intermediate catheter 189 may have a fixed curve towards the tricuspid valve 15 or may include steerable catheter mechanisms to allow the physician to deflect the distal end of the catheter 189 towards the tricuspid valve 15.
  • the removal catheter 100 is advanced through the inner intermediate catheter 189 so that it passes out of the distal end of the inner intermediate catheter 189, into the right atrium 16, through the tricuspid valve 15, and into the right ventricle 13. Since the leaflet clip 40 is typically positioned in the middle of the valve 15 (e.g., similar to the top view of the mitral valve in Fig. 6), creating to side valve openings, the removal catheter 100 is preferably positioned on either side of the leaflet clip 40.
  • the inner control member 108 is further distally advanced relative to the outer tubular sheath 110 so that the basket 102 and cutting loop 104 are deployed, expanded, and positioned in the right ventricle 13.
  • the opening of the basket 102 and the opening of the cutting loop 104 are both or oriented so that they face the leaflet clip 40.
  • a plane 103A of the face of the opening of the basket 102 and the opening of the cutting loop 104 may be an angle 103C within a range of about 0 degrees and 90 degrees relative to an axis 103B of the inner control member 108 (e.g., about 45 degrees).
  • the removal catheter 100 is proximally retracted relative to the inner intermediate catheter 189, so that the cutting loop 104 and basket 102 are positioned over and beyond the leaflet clip 40.
  • the inner control member 108 is proximally retracted, causing the cinching loop 106 and the cutting loop 104 to decrease in diameter, closing the top opening of the basket 102.
  • RF energy is delivered to the loop 104, allowing the uninsulated portion 104 to cut areas of the leaflet tissue adjacent to the leaflet clip 40 and thereby freeing the leaflet clip 40 from the tricuspid valve 15.
  • the basket 102 and leaflet clip 40 can either be retracted through the inner intermediate catheter 189 or all of the catheters can be removed together as a single unit simultaneously.
  • any of the embodiments of the present specification can be used according to the access and delivery methods described in this application. Additionally, further methods can be used with these access and delivery methods, such as delivery and implantation of an artificial valve (either mitral or tricuspid valve).
  • an artificial valve either mitral or tricuspid valve.
  • the previously described removal catheter embodiments have included a basket or similar device to capture the heart valve therapy, such as a leaflet clip 40, different capture approaches and devices are also contemplated.
  • Figures 70-72 illustrates a removal catheter 200 for removing a heart valve therapy leaflet clip 40.
  • the removal catheter 200 includes an elongated piercing member 202 that pierces into the device, and an outer cutting catheter 204 that is disposed over the piercing member 202.
  • the elongated piercing member 202 can be a wire, catheter or similar elongated device having a distal end that is sharpened, helically shaped, an expandable barb, or rotational elements, such that the elongated piercing member 202 can be pressed into a top of the leaflet clip 40 (and optionally rotated or expanded) to initially engage or capture the leaflet clip 40, as seen in Figure 70.
  • the outer cutting catheter 204 is distally advanced over the elongated piercing member 202 until its distal end contacts the top surface of the valve leaflets, as seen in Figure 71.
  • the outer cutting catheter 204 can be configured to cut the leaflet tissue with a variety of different mechanisms, such as mechanical (e.g., rotation or forward pressure) and/or electrosurgical cutting device (i.e. , electrical or cryo).
  • mechanical e.g., rotation or forward pressure
  • electrosurgical cutting device i.e. , electrical or cryo
  • Figures 73-75 illustrate a removal catheter 210 that is similar to the previously described catheter 200, except that the cutting catheter 212 also includes a grasping mechanism having to two articulating jaw members connected via a joint ( Figure 76).
  • the outer cutting member 212 is distally advanced over the elongated piercing member 202 until it contacts the top surface of the leaflets ( Figure 74).
  • the articulating jaw members preferably include tissue cutting mechanisms on their ends, such as blades or electrical/cryo electrosurgical cutting device mechanisms, allowing the leaflet tissue around the leaflet clip 40 to be cut.
  • FIGs 77-82 illustrates another embodiment of a removal catheter 220 that embeds in the previously placed leaflet clip 40, followed by passage of a loop-based tool 224 that encapsulates, cuts, and removes the clip 40.
  • the loopbased removal catheter 220 includes an anchoring mechanism 226 connected to a central push rod 227, side push rods 223, and pushability elements 225.
  • Figure 78 illustrates an end face view of the loop-based removal catheter
  • the anchoring mechanism 226 is advanced into the heart valve therapy hardware (i.e., leaflet clip 40) using the central push rod 227 and pushability element 125.
  • the side push rods 223 then are used push on the pushability element 225 to wrap the loop-based removal catheter 220 completely or partially around the leaflet clip 40. Cutting is performed mechanically or electrically followed by removal of the targeted tissue.
  • Figures 83-88 illustrate a removal catheter 230 that embeds in the previously placed heart valve therapy (e.g., leaflet clip 40), followed by passage of a tool that expands the leaflet clip 40, followed by removal of the hardware.
  • the steerable guide catheter 231 is used to position the removal catheter 232, which contains the expanding tool 234 for expanding the leaflet clip 40.
  • the expanding tool 234 may have barbs, anchors, or embedding mechanisms to remove or grasp native or foreign, leaflet or tissue material from the tissue clip 40.
  • an anchor 235 is advanced and implanted.
  • the expanding tool 234 is advanced inside the leaflet clip 40.
  • the expanding tool 235 is mechanically expanded to expand the leaflet clip 40.
  • the expansion may be aided by electrification, heating, hydraulic means, rotation, internal or external ultrasound or energy.
  • the tissue is cut from the leaflet clip 40.
  • the expansion tool 235 is closed and then removed, free from the leaflets.
  • Figure 88 shows a similar approach with a balloon expandable element 129.
  • Figures 89 and 90 are cross-sectional views of the mitral valve 20 that has been treated with a heart valve therapy comprising one or more chordal structures 50.
  • the chordal structures 50 typically include a chord or strand 52 that is connected to a leaflet via anchors 54 and to the left ventricle.
  • the cord 52 may be anchored on the ventricular side of the leaflet 24 ( Figure 89) or the atrial side of the leaflet 24 ( Figure 90).
  • similar device can be used to remove the chordal structures 50 as were used to remove a leaflet clip 40.
  • Figures 91 -92 illustrate a removal tool 240 for cutting and capturing previously placed heart valve therapy involving cord or chordal structures implanted into the leaflets.
  • the procedure is performed with a previously described cutting catheter 212 with capabilities of opening, closing, electrification, and removal of the hardware, similar to the above description for other heart valve therapy in Figures 73- 76.
  • a flow limiter can be used to help limit flow during any of the procedures described in this specification.
  • Figure 109 illustrates the embodiment of the removal catheter 100 of Figure 60 with an additional flow limiting device 341 .
  • This flow limiting device 341 can be positioned within the region of valve 20 (e.g., through the valve 20) before, during , or after the removal of the clip 40 and is maintained in the valve region to manage the blood flow of the patient by limiting the blood flow.
  • the flow limiting device 341 can be any flow limiter known to those familiar with the art, such as but not limited to, a balloon, a stent with covering, or a catheter.
  • the flow limiting device 341 can be introduced independently as shown here via delivery catheters 342 and 343. Additionally, the flow limiting device 341 can be integral into the delivery mechanism, such as the inner steerable catheter 180. Alternatively, the flow limiting device 341 can be the delivery system of another therapy such as but not limited to a heart valve. [00252] It can be helpful when performing the cutting procedures of this specification to maintain good mechanical contact or force between the leaflet tissue and the cutting element (e.g., cutting wire 104), particularly when using RF energy as the mechanism for performing the cutting. This contact or force can be important for ensuring that the electrode of the cutting element/loop is not exposed to a large amount of blood.
  • the cutting element e.g., cutting wire 104
  • impedance seen by the generator will typically be low (e.g., 0-300 Ohms) when a cutting element is mostly exposed to the patient’s blood. This low impedance may result in an insufficient voltage to cut through the tissue. In such circumstances, some RF energy generators will increase the current to maintain a constant power level.
  • the impedance seen by the generator will be relatively higher (e.g., greater than 300 Ohms) or more resistive to the current. This greater resistance may cause the generator to increase the voltage output to try to maintain constant power. Once the voltage reaches a certain level, the tissue cutting process begins and will continue so long as the cutting element is continuously in contact with target tissue.
  • a cutting loop may be cinched on the atrial side of the valve clip 40 without the need for any further “counter force” against the clip 40 (as described in earlier embodiments/methods of this specification), 2) a counter force on the valve clip 40 may be helpful or needed to stretch the tissues such that the cutting loop can be cinched on the atrial side of the valve clip 40, 3) a counter force may be helpful or needed and the cutting loop must first cut through some leaflet side tissues before it can be cinched on the atrial side of the valve clip 40, and 4) a cutting snare can be used to substantially release the engaged tissue from the clip 40 and then can be used to facilitate engagement of cutting loop and basket.
  • the counter force helps to stabilize the valve clip 40 and leaflets such that the cutting loop can be pulled firmly against the leaflet edge. Once it is firmly pressed against the leaflet tissue, a first cut can be performed by pulling the cutting loop until it is positioned on the atrial side of the valve clip 40, and then the cutting loop can be cinched, and the final cut completed. [00261] In the fourth scenario, removal of the engaged tissues may be necessary to facilitate the snare engagement and allow the snare to provide the counter force to stabilize the valve clip.
  • the steerable catheter 180 used to deliver the cutting and retrieval catheter may be used to press on the valve leaflets 22, 24 and valve clip 40 to create counter force towards the left ventricle 14.
  • a distal edge around its distal opening can be positioned against the valve leaflets and/or the valve clip 40.
  • a pushing catheter 470 can be used to push on the valve clip 40 from the left atrial side of the valve clip 40 toward the left ventricle, as seen in Fig. 142.
  • An elongated standard catheter or steerable catheter can be used, or the catheter 470 may further include a specialized distal end portion 472 to help press or engage the valve clip 40.
  • the distal end portion 472 may be selectively enlargeable (e.g., a balloon or expandable mesh structure) that can be expanded to better contact the valve clip 40.
  • the distal end portion 472 may alternately or additionally have a blunted distal end.
  • the distal end portion 472 may alternately or additionally be configured to mechanically affix to the valve clip 40 or even to leaflet tissue immediately adjacent to the valve clip 40.
  • the devices and mechanisms shown in Figs. 70-100 may be used to affix to the valve clip 40 or to the adjacent tissue.
  • the catheter 470 can be pushed against the valve clip 40 from the left atrium 12 towards the left ventricle 14, and then the cutting loop can be positioned between the atrial side of the valve clip 40 and the leaflets 22, 24. Finally, the cutting loop (e.g., of any of the embodiments of this specification) can be activated and the cut through the leaflet tissue completed.
  • valve clip 40 can be pulled from a location within the left ventricle 14, further into the left ventricle 14 to create the counter force, allowing the cutting loop to be positioned and to cut the tissue as previously described.
  • Figures 110 and 111 illustrate one embodiment of a removal system 400 that can be used to pull the valve clip 40 into the left ventricle 14 to create counter force, and includes both a cutting and capture catheter 403 and a separate snare catheter 401 (or alternately a separate cutting catheter and separate capture catheter).
  • the snare catheter 401 can be used to first grasp the valve clip 40 and pull it further into the left ventricle 14, while the cutting and capture catheter 403 can be used to cut the valve leaflets 22, 24 and capture the valve clip 40. Note that this technique can be used on other valves, such as a tricuspid valve, as well.
  • the cutting and capture catheter 403 is generally similar to the previously embodiments and may include any of the variations previously discussed in that regard.
  • the cutting and capture catheter 403 may include a basket 102 and a cutting loop 404 connected to an elongated inner control member 108 that moves all of the components into and out of a tubular jacket or sheath 110.
  • the basket 102 may include a basket tip 414 at its distal end.
  • the basket tip 414 can serve one or more of the following purposes.
  • the basket tip 414 can connect to or contain the ends of the wires that make up the basket 102.
  • the basket tip 414 includes a cylindrical wall portion with a plurality of apertures 414B through which the ends of the wires pass into, thereby preventing the wires ends from unraveling or from damaging the patient.
  • the wires ends can be tied, welded, or adhered within the basket tip 414. Alternately, the ends of the wires can be welded or melted together with the basket tip 414 without the need for apertures 414B.
  • the basket 102 can be woven with a single wire, in which case only two apertures 414B would be needed, or woven with a plurality of wires, in which a plurality of apertures 414B (e.g., two for each wire) may be needed.
  • the basket tip 414 includes an atraumatic distal end shape 414A that helps prevent the basket tip 414 from damaging tissue within the patient.
  • the atraumatic distal end shape 414A can be spherical, rounded, oval, or conical. Again, this basket tip 414 may also be used with any of the other embodiments of this specification.
  • the cutting and capture catheter 403 further comprises a cutting element or loop 404 that can be structured and used similar to previously described embodiments.
  • the present cutting loop 404 has a saddle shape, similar to cutting loop 350. That is, the cutting loop 404 has side portions that form a dip or curve distally downward and then proximally upward to form a valley shape. This shape can be desirable because, as the cutting loop 404 is proximally retracted inward into the outer sheath 110, the loop 404 may maintain a desirable cutting angle relative to the remaining elements of the catheter 403.
  • the cutting loop 404 formed a perpendicular right angle relative to the inner control member 108, as that right angle joint is retracted into the outer sheath 110, it may tend to angle the loop 404 downward.
  • the curved or saddle shape helps maintain the end of the loop 404 within a desired vertical range as it is retracted. This may be particularly helpful if the electrodes of the cutting loop 404 are located at the side of the loop opposite of the inner control member 108.
  • this cutting loop 404 can be used with any of the embodiments described in this specification.
  • the snare catheter 401 includes a snare loop 420 that is connected on or near the distal end of an inner control member 418 (which is similar to member 108) that moves longitudinally within an outer tubular jacket or sheath 416. This allows the inner control member 418 to move the snare loop 420 into and out of the sheath 416.
  • the outer tubular sheath 416 may be open at the bottom similar to sheath 110 or may include a tip member 422 with an opening in its sidewall that extends into the interior lumen of the sheath 416.
  • the snare loop 420 may include a previously described cutting element (e.g., an RF electrode near its tip) that allows it to engage tissue surrounding the clip and at least partially cut some of this tissue to initially facilitate the capture and removal of the valve clip 40. Additionally cutting and capture procedures can then be performed. This initial removal of at least some of the engaged tissue may be necessary to facilitate the engagement of the snare loop 420 and allow the snare loop
  • a previously described cutting element e.g., an RF electrode near its tip
  • a channel or valley can be cut into the tissue surrounding the valve clip 40 which can then allow the snare loop 420 to more robustly engage the valve clip 40.
  • Figures 145 and 146 which includes RF electrode
  • the snare loop 420 can have a variety of different shapes that are configured to grip a valve clip 40.
  • Figs. 114 and 115 illustrate a “saddle- shaped” or arc-shaped loop similar to that of the cutting loop 404 (i.e. , sides that curve distally downward and then back upward as they connect to each other to form an arc or concave shape).
  • the curve shape can prevent the far end or tip of the snare loop 420 from moving distally downwards beyond the distal end of the distal end of the snare catheter 401 .
  • the loop 420 since the far end of the snare loop 420 is angled upwards when fully extended out of the catheter 401 , as it is pulled in, the loop 420 may angle itself distally downwards, but since the far end is curved proximally, the distal angles of the loop 420 are not enough to move the loop 420 off o the valve clip 40.
  • the proximal curve of the loop 420 is sufficient that the far end of the loop does not position itself distally beyond a distal end of the snare catheter 401.
  • a snare loop 424 can have a generally circular shape that may optionally include an indentation or curved segment 424A positioned opposite of the outer sheath 416 and extending radially outward from the circular shape. While only one notch or indentation 424A is illustrated, a plurality of segments 424A may also be positioned partially or completely around the snare loop 424.
  • the snare loop 424 has an imparted shape-memory shape such that it connects to the inner control member 418 at about 90 degrees. In some circumstances, as that 90-degree bend is pulled into the snare catheter 401 , it may angle or deflect the loop 424 downward and could potentially move the loop 424 off the valve clip 40. In contrast, the saddle-shaped snare loop 420 has a distal/downward arc curve, and therefore as the loop 420 is pulled into the snare catheter 401 , it helps maintain the original orientation of the loop 420 and thereby better maintains the loop 420 on the valve clip 40.
  • the snare loop 420 can further include features that enhance its grip on a valve clip 40.
  • a frictional coating or frictional sleeve can be placed over portions of or the entire snare loop, as seen with the snare loop 420 in Figs. 114 and 115.
  • a plurality of relatively small protrusions 426A can be located on portions of or all of the inner radial surface/side of snare loop 426, as seen in Fig. 117.
  • the snare loop can be composed of a wire coil in either a compressed configuration 428A (Fig. 118) or a longitudinally expanded configuration 428B (Fig. 119) which creates varying levels of texture and therefore increases the grasp of the loop on a valve clip 40.
  • these different loop shapes and frictional engagement features can be mixed and matched with each other and any embodiment in this specification.
  • the snare catheter 401 and snare loop 420 is previously described as being used to grasp a valve clip 40, it can be used for other purposes as well. For example, it can be used to capture other tissues. It may be desirable to remove calcified nodules within the valve leaflets to facilitate placement of a valve. It may be used to capture and remove valve leaflet tissue to facilitate flow after a replacement valve is inserted. It may be used to remove chordae tendinea to facilitate motion of the valve. In that respect, the snare loop 420 can be used to grab such tissue while the cutting loop 404 is used to cut the tissue. However, it can also be helpful to include a cutting element (e.g., RF electrode) on the snare loop 420 to help cut such tissue first.
  • a cutting element e.g., RF electrode
  • the snare catheter 401 may further include a tip member 422 at the distal end of the outer tubular sheath 416, as best seen in Figs. 120 and 121.
  • the tip member 420 can be configured to maintain the snare loop 420 in a desired angle or orientation relative to the outer tubular sheath 416 and the valve clip 40. Since valve clips 40 tend to have a generally conical or “V” shape, as shown earlier in this specification, a cinching snare loop may have a tendency to squeeze off of the valve clip 40 as it is tightened. This tendency to slip off may be increased if the snare loop 420 is positioned at a dramatic angle relative to a vertical axis of the valve clip 40.
  • the angle of the snare loop 420 may increase relative to the axis as it is pulled into the outer tubular sheath 416, potentially slipping off the valve clip 40.
  • the tip member 422 includes an opening 422A through its side wall, along with an angled or curved surface 422B that is configured to direct the snare loop 420 out of the opening 422A at a generally perpendicular angle relative to an axis of the outer tubular sheath 416 and axis of the valve clip 40.
  • the tip member 422 can include features that help engage and/or create friction with the valve clip 40 so that when the snare loop 420 cinches the valve clip 40 against the tip member 422, the features help prevent the valve clip 40 from slipping out of the snare loop 420.
  • the shape of the opening 422A may include relatively sharp or abrupt comers around it, which can help push into the valve clip 40 to retain its position.
  • a proximal channel 422C and a distal channel 422D can extend from the main opening 422A to provide additional areas with sharp or abrupt comers that extend a greater longitudinal distance.
  • the tip member 422 can include a plurality of ridges or grooves 422E on the surface of the tip member 422, adjacent to the opening 422A and/or the channels 422C, 422D. These ridges or grooves 422E can be relatively straight and circumferentially oriented relative to the opening 422A and/or the channels 422C, 422D, or can have different patterns, such as waves or zig-zag patterns.
  • a plurality of spikes, hooks, or similar sharp shapes can extend from the side surface around the main opening 422A or other nearby locations. Any combination of these engagement features can be used together to provide surfaces that may better engage the valve clip 40 upon contact.
  • the snare catheter 401 may also include a handle 440 that is configured to retract the inner control member 418, and therefore the snare loop 420, in a controlled manner.
  • the handle 440 allows predetermined and limited amounts of force to be applied to the snare loop 420 while also providing the ability to lock the snare loop 420 position or force at the desired level. This allows the valve clip 40 to be grasped relatively firmly without enough force to break the catheter 401 and further allows this force to be maintained throughout the procedure without the necessity to hold portions of the handle 440 during most of the procedure.
  • the handle 440 may have different possible mechanisms for controlling and locking the position/force of the snare loop 420.
  • Figs. 125 and 126 illustrate one such example mechanism having an outer housing 442 forming a generally cylindrical shape and a knob 448 located at a proximal end of the housing 442 and that is configured to be pulled proximally out from the housing 442 (i.e., to the right in the figures). Pulling the knob 448 out proximally also proximally pulls the inner control member 418, causing the snare loop 420 to retract proximally into the opening of the tip 422.
  • the force applied to the knob 448 can be limited or can increase in resistance as the knob 448 is pulled out by a spring 450 located in the housing 442.
  • the spring 442 can be connected to either the inner control member 418 or a distal portion 440 of the knob 448, as well as to an interior of the housing 442 such that when the knob 448 is pulled proximally, the spring 450 either compresses or expands to generate increased resistance.
  • the force applied by the spring 450 can be optimized to apply a constant predetermined tension throughout the length the knob 448 can be pulled, or alternately can apply increasing tension the further proximally the knob 448 is pulled.
  • the handle 440 may also include a locking mechanism that can lock the position of the inner control member 418 relative to the housing 442 and outer sheath 416.
  • the locking mechanism comprises a longitudinal slot 444 that extends along at least a portion of the length of the housing 442.
  • a tracking peg 446 is fixed to the inner control member 418 and positioned at least partially within or through the slot 444. As the knob 448 is pulled proximally back, the tracking peg 446 moves along the length of the slot 444.
  • the knob 448 can be rotated so that the tracking peg 446 passes sideways relative to the length of the slot 444 into one of a plurality of slot branches.
  • These slot branches are preferably shaped to retain the position of the tracking peg 446 and therefore the inner control member 444 when the user releases the knob 448.
  • the slot branches can be angled somewhat distally so that the distal force of the spring 450 maintains the tracking peg 446 within the slot branch, thereby releasably locking the inner control member 418 in place.
  • the handle may also 440 include a port 452 that is in communication with the interior of the handle housing 442 and outer sheath 416. This port 452 can be used for supplying saline, contrast, or similar fluids during a procedure.
  • the handle 440 may also include an electrical connection to the RF generator and to the snare loop 420 (if the snare loop includes an RF electrode or similar cutting element) to be used for supplying energy to the cutting snare 420 during a procedure. As previously described, in some circumstances it may be helpful for the snare loop 420 to include a cutting element to cut at least some tissue surrounding a valve clip 40 or other heart valve therapy so that the snare loop 420 can better engage the valve clip 40.
  • both the cutting and capture catheter 403, and the snare catheter 401 may be included and delivered through the same delivery catheter (e.g., steerable catheter 180).
  • the cutting and capture catheter 403, and the snare catheter 401 may also be separately delivered in independent delivery catheters or without any overlying catheter, depending on the specific procedure.
  • Figures 127-130 illustrate an example technique of using the removal system 400, including the cutting and capture catheter 403, and the snare catheter 401 . While a specific removal system 401 is illustrated and discussed, variations on this procedure are also contemplated, including the use of the different embodiments described in this specification.
  • a delivery catheter e.g., a steerable delivery catheter 180
  • the tip of the catheter 180 may be advanced through the leaflets 22, 24 and into the left ventricle 14 initially. This may help prevent either the cutting and capture catheter 403 or the snare catheter 401 from becoming tangled in any chordae extending from or near the leaflets 22, 24.
  • the basket tip 414 of the basket 102 may be positioned at or partially beyond the opening of the delivery catheter 180 to help create a generally smooth surface that will not “catch” or otherwise get stuck when passing through the leaflets 22, 24 or the nearby chordae.
  • the cutting and capture catheter 403 and the snare catheter 401 are advanced out of the catheter 180 and into the left ventricle 14. Initially, the opening 422A of the tip member 422 is oriented towards the valve clip 40. If the snare loop 420 is not already deployed outward, the inner control member 418 is moved distally via the handle 440 to cause its deployment and expansion. The snare loop 420 is aligned with the valve clip 40 and then the snare catheter 401 is moved proximally so that the snare loop 420 surrounds the valve clip 40, as seen in Figure 127.
  • the basket 102 and cutting loop 404 can be either be positioned in a different or opposite rotational orientation as the snare loop 420, and/or distally beyond the snare loop 420.
  • the snare loop 420 is cinched or tightened around the valve clip 40 until the valve clip 40 is pressed against the tip member 422. This can be achieved by proximally retracting the inner control member 418 via the handle 440 (e.g., by pulling back the knob 448 and locking its position within the slot 444. If not already aligned, the cutting loop 404 and the basket 102 are vertically aligned with both the valve clip 40 and the snare catheter 401 .
  • the snare catheter 401 is advanced distally to create counter force to pull the valve clip 40 toward or further into the left ventricle 14.
  • the cutting and capture catheter 403 is retracted proximally (either at the same time as the counter force is created or prior to it) so that the cutting loop 404 is positioned on the atrial side of the valve clip 40, between the clip 40 and the leaflets 22, 24.
  • the basket 102 is positioned partially or nearly completely around the valve clip 40, as well as the distal portion of the snare catheter 401 (e.g., the snare loop 420 and distal tip 422).
  • both the cinching loop 106 and cutting loop 404 are cinched or reduced in size while the counter force from the snare catheter 401 is maintained. As previously discussed, this counter force allows good contact between the electrodes of the cutting loop 404 and the leaflet tissue. Hence, when the electrodes of the snare loop 404 are activated, a quick, clean cut can be performed through the tissue, causing the valve clip 40 to be completely removed and captured by the basket 102. Finally, the cutting and capture catheter 403 and the snare catheter 401 can be withdrawn at least partially back into the delivery catheter 180 and removed from the patient.
  • the distal end/opening of the delivery catheter 180 may remain in the left atrium 12 or can be advanced back into the left ventricle 14 when the cutting and capture catheter 403 and the snare catheter 401 are retracted back within it.
  • the delivery catheter 180 passes back into the left ventricle 14 to then retract the cutting and capture catheter 403 and the snare catheter 401 .
  • the chords of the valve can inhibit the delivery catheter 180 from passing back through into the left ventricle 14.
  • the distal end of the delivery catheter 180 may not be tapered enough and therefore may “catch” on the chords.
  • chord dilator that can be positioned partially out of the distal opening of the delivery catheter 180 when transitioning through the leaflets 22, 24 and chords.
  • a chord dilator may include a tapered and/or angled distal surface and can be sized to radially occupy most or all of the opening of the delivery catheter 180.
  • chord dilator 432 can be seen best in Figs. 134-137.
  • the chord dilator 432 includes body having a bottom surface 432D that has a bias angle (i.e., an edge that forms an angle, such as about 45 degrees, relative to a vertical axis of the dilator 432).
  • the bottom surface 432D may be rounded or somewhat conical to help create a transition with the delivery catheter 180.
  • the chord dilator 432 may include a similar-shaped top surface 432C, which may be helpful in deflecting chords in both directions for either the mitral or tricuspid valve.
  • the chord dilator 432 includes two passages 432A and 432B; one passage 432A to accommodate the snare catheter 401 and another 432B to accommodate the cutting and capture catheter 403.
  • the chord dilator 432 may only have a single passage that accommodates only one of the snare catheter 401 or the cutting and capture catheter 403.
  • the passages preferably allow their respective catheters to rotate within it during a procedure.
  • one of the passages may be a “C” shape (i.e., does not completely surround a catheter) such that it allows one of the catheters to decouple from the chord dilator 432.
  • radiopaque markers 432E may also be included within the chord dilator 432.
  • the radiopaque markers 432E may be located on opposed circumferential sides of the chord dilator 432 and extend at least partially between the proximal and distal end of the chord dilator 432.
  • the snare catheter 401 and/or the cutting and capture catheter 403 are moved relative to the delivery catheter 180 so that they position the chord dilator 432 partially into the distal opening of the delivery catheter 180, similar to that seen in Fig. 135. Then, the delivery catheter 180, the snare catheter 401 , and the cutting and capture catheter 403 are all distally advanced until the distal end of the delivery catheter 180 is positioned within the left ventricle 14.
  • chord dilator 432 may be configured only to connect the snare catheter 401 and the cutting and capture catheter 403, without any specific surfaces for chord dilation. In that respect, the chord dilator 432 may primarily be used to maintain the two catheters parallel to each other and not necessarily for chord dilation, which may be useful for achieving a desired alignment during a procedure.
  • the chord dilator 432 may alternately include three passages. For example, one passage 432A to accommodate the snare catheter 401 , another 432B to accommodate the cutting and capture catheter 403, and another to facilitate a passage of a guidewire.
  • the chord dilator 432 also can be used to facilitate the relative axial alignment of the snare, cutting loop, and basket. The location of the other members relative to the chord dilator 432 changes the length of the free member arms and hence controlling the distance between and angles the axis of the members
  • the snare catheter 401 is previously described as being used to grasp a valve clip 40, it can be used for other purposes as well. For example, it can be used to grab or snare a guidewire or a Fogarty balloon during a procedure (e.g., during a transapical approach) to help pull these components through a target valve and prevent them from becoming tangled or stuck.
  • the removal system 400 is previously described as being delivered through an outer transeptal guide catheter 182 or similar catheter.
  • the removal system 400 can be further configured to have a guidewire pathway or passage so that it can be delivered over a guidewire 430.
  • the guidewire may have a more delicate force and stiffness transition to the tissues as the removal system is presented, ensuring safe introductions in to various anatomies.
  • Figs. 131-133 illustrate one example removal system 400 with such a guidewire passage.
  • the guidewire passage extends from a proximal opening into the outer sheath 416 of the snare catheter 401 , through an opening in the distal tip member 422, through the basket 102, and finally through a passage in the basket tip 414.
  • Fig. 138A illustrates a guidewire 430 that extends along the outside of the basket 405 and into a passage within the basket tip 415 that opens near its outer top and its bottom, thereby allowing the guidewire 430 to pass through.
  • the guidewire 430 never passes into the interior of the basket 405.
  • the guidewire 430 may pass through one of the cells of the basket 405, enter an interior opening to the passage of the basket tip 415, and extend distally out of the basket tip 415.
  • the guidewire 430 may proximally extend through only the steerable catheter 180, as seen in Fig. 138A,or may extend through passages in either the snare catheter 401 or the cutting and capture catheter 403. Alternately, the guidewire 430 may pass completely externally of the steerable catheter 180, snare catheter 401 , or cutting and capture catheter 403 in the proximal direction (except for through the basket tip 415), as seen in Fig. 138B.
  • the basket tip 415 may include a guidewirelike pigtail or curved wire 431 attached and extending distally from the tip 415 to help pass through the valve and prevent damage to different heart structures.
  • a guidewire 430 for delivery of the removal system 400 may facilitate crossing through a valve with smaller orifices, which is particularly common with valves that have multiple valve clips 40 implanted. Navigating over a guidewire 430 may also allow two valve clips 40 to be removed easier.
  • a catheter with a cutting loop 420 can be advanced over the guidewire 430 and used to cut the leaflet tissue between both valve clips 40, allowing them to spread apart and therefore allow for easier sequential capture via successive removal systems 400.
  • this procedure may include placing a steerable catheter 180 within the left atrium, navigating a guidewire 430 through the target orifice of the valve, advancing a cutting and capture catheter 403 over the guidewire 430, removing the guidewire 430, cutting and extracting the valve clip 40 with the cutting and capture catheter 403, removing the cutting and capture catheter 403, again advancing the guidewire 430 through the target orifice of the valve, and repeating the removal process.
  • the steerable catheter 180 may be left in place after removing the first valve clip 40 if it is sized large enough for complete removal of the valve clip 40; otherwise the steerable catheter 180 can be removed and a second steerable catheter 180 can be placed.
  • the cutting and capture catheter 403 may also be desirable in some embodiments and procedures for the cutting and capture catheter 403 to have a basket 460 that can expand or stretch from a longitudinally compressed configuration. This may allow for a basket 460 with a single size to accommodate different size valve clips 40, instead of needing several different sized baskets, and may also allow the valve clip 40 to be “tented” by the snare catheter 401.
  • Fig. 140 illustrates a basket 460 in a longitudinally compressed configuration
  • Fig. 141 illustrates the basket 460 in an expanded configuration.
  • the longitudinally stretchable functionality of the basket 460 can be achieved in several different ways.
  • the basket 460 can be braided or woven from one or more wires composed of a shape memory material (e.g., Nitinol), which is then heat set to the compressed configuration (Fig. 140).
  • the braid pattern may also be configured to generally bias or at least facilitate the basket 460 in its compressed configuration.
  • the basket 460 may include longitudinal elastic tethers or an elastic outer cover that bias the basket 460 to its compressed configuration.
  • the wires of the basket 460 may be composed of an elastic material that allows for stretching.
  • one or more of the struts/wires of the basket 460 may be coiled to form springs.
  • a plurality of pull wires that connect to the basket 460 and to a proximal end of the device near the user may maintain the basket 460 in a compressed configuration and may be released proximally as needed to increase the diameter and/or length of the basket 460.
  • Fig. 143A illustrates a basket 102’ that has a generally conical shape.
  • the expanded basket shape tapers from about 30 mm to about 6 mm.
  • the tapered shape creates a smooth, atraumatic shape without any large edges. This can help prevent the steerable catheter 180 from catching or getting stuck as it is crossing through the valve, leaflets, and chordae. This shape may also allow the basket to be loaded into the steerable catheter 180 or other catheters easier.
  • the basket 102 While the inclusion of the basket 102 is desirable for capturing a valve clip 40 or other heart valve therapy, it is also possible to eliminate the basket 102 from the cutting and capture catheter 403, as seen in Fig. 144.
  • the snare loop 420 (and possible other previously described clip engagement features) can be used to grab the valve clip 40 while the cutting loop 404 is proximally moved over the clip 40 and snare loop 420 and activated to cut the desired valve tissue.
  • the snare loop 420 can maintain its hold on the valve clip 40 and proximally withdraw the clip 40 from the patient.
  • the terms “substantially” or “generally” refer to the complete or nearly complete extent or degree of an action, characteristic, property, state, structure, item, or result.
  • an object that is “substantially” or “generally” enclosed would mean that the object is either completely enclosed or nearly completely enclosed.
  • the exact allowable degree of deviation from absolute completeness may in some cases depend on the specific context. However, generally speaking, the nearness of completion will be so as to have generally the same overall result as if absolute and total completion were obtained.
  • the use of “substantially” or “generally” is equally applicable when used in a negative connotation to refer to the complete or near complete lack of an action, characteristic, property, state, structure, item, or result.
  • an element, combination, embodiment, or composition that is “substantially free of” or “generally free of” an ingredient or element may still actually contain such item as long as there is generally no measurable effect thereof.
  • any reference to "one embodiment” or “an embodiment” means that a particular element, feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment.
  • the appearances of the phrase “in one embodiment” in various places in the specification are not necessarily all referring to the same embodiment.
  • the terms “comprises,” “comprising,” “includes,” “including,” “has,” “having” or any other variation thereof, are intended to cover a nonexclusive inclusion.
  • a process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
  • "or” refers to an inclusive or and not to an exclusive or. For example, a condition A or B is satisfied by any one of the following: A is true (or present) and B is false (or not present), A is false (or not present) and B is true (or present), and both A and B are true (or present).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Cardiology (AREA)
  • Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Otolaryngology (AREA)
  • Plasma & Fusion (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Surgical Instruments (AREA)
  • Prostheses (AREA)

Abstract

L'invention concerne un cathéter de récupération et des méthodes d'utilisation pour retirer une thérapie de valve cardiaque telle qu'un clip à valvule ou un cordon à valvule artificiel. Le cathéter de récupération peut comprendre un élément de coupe et un panier, un élément de perçage, un mécanisme de serrage ou un dispositif de préhension similaire. La méthode consiste d'abord à disposer un cathéter dans la région de la thérapie de valve cardiaque, ensuite à manipuler le cathéter et les instruments associés pour couper un tissu au besoin, enfin à retirer la thérapie de valve cardiaque et à récupérer le cathéter.
EP21873270.9A 2020-09-22 2021-09-21 Méthode et dispositif pour retirer une thérapie de valve cardiaque Pending EP4216839A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063081504P 2020-09-22 2020-09-22
US202163144399P 2021-02-01 2021-02-01
US202163187285P 2021-05-11 2021-05-11
PCT/US2021/051258 WO2022066621A1 (fr) 2020-09-22 2021-09-21 Méthode et dispositif pour retirer une thérapie de valve cardiaque

Publications (2)

Publication Number Publication Date
EP4216839A1 true EP4216839A1 (fr) 2023-08-02
EP4216839A4 EP4216839A4 (fr) 2024-10-23

Family

ID=80845766

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21873270.9A Pending EP4216839A4 (fr) 2020-09-22 2021-09-21 Méthode et dispositif pour retirer une thérapie de valve cardiaque

Country Status (4)

Country Link
EP (1) EP4216839A4 (fr)
JP (1) JP2023551755A (fr)
CA (1) CA3192683A1 (fr)
WO (1) WO2022066621A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021072331A1 (fr) 2019-10-09 2021-04-15 Nasser Rafiee Systèmes et procédés d'excision, de découpe et d'élimination de tissus
WO2023200706A1 (fr) * 2022-04-15 2023-10-19 Edwards Lifesciences Corporation Procédés et appareil d'élimination de dispositifs de réparation de valvule
WO2023229942A1 (fr) * 2022-05-27 2023-11-30 Edwards Lifesciences Corporation Dispositif de transection péricardique avec électrode à forme définie

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662671A (en) * 1996-07-17 1997-09-02 Embol-X, Inc. Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries
US5735289A (en) * 1996-08-08 1998-04-07 Pfeffer; Herbert G. Method and apparatus for organic specimen retrieval
US6752813B2 (en) * 1999-04-09 2004-06-22 Evalve, Inc. Methods and devices for capturing and fixing leaflets in valve repair
AU2002237810A1 (en) * 2001-01-12 2002-07-24 Granit Medical Innovation, Inc. Medical cauterization snare assembly and associated methodology
US7618437B2 (en) * 2005-07-15 2009-11-17 Granit Medical Innovation, Llc Endoscope retrieval instrument assembly
US10792056B2 (en) * 2014-06-13 2020-10-06 Neuravi Limited Devices and methods for removal of acute blockages from blood vessels
US11963712B2 (en) * 2016-06-20 2024-04-23 Evalve, Inc. Transapical removal device
CN111432743A (zh) * 2017-11-30 2020-07-17 阿列维安特医疗公司 用于心房间吻合的经导管装置
US12102531B2 (en) * 2018-10-22 2024-10-01 Evalve, Inc. Tissue cutting systems, devices and methods
CA3146170A1 (fr) * 2019-07-09 2021-01-14 Amx Clip Management, Llc Procede et appareil de retrait de therapie de valvule cardiaque

Also Published As

Publication number Publication date
CA3192683A1 (fr) 2022-03-31
JP2023551755A (ja) 2023-12-13
EP4216839A4 (fr) 2024-10-23
WO2022066621A1 (fr) 2022-03-31

Similar Documents

Publication Publication Date Title
US11986391B2 (en) Percutaneous delivery systems for anchoring an implant in a cardiac valve annulus
JP7463430B2 (ja) 人工腱索修復デバイス及びそのデリバリー
US11331189B2 (en) Systems and devices for setting an anchor
US20220265311A1 (en) Method And Apparatus For Removing Heart Valve Therapy
WO2022066621A1 (fr) Méthode et dispositif pour retirer une thérapie de valve cardiaque
JP5318710B2 (ja) 心臓弁修復のための送達装置および方法
US20200276017A1 (en) Percutaneous delivery systems for anchoring an implant in a cardiac valve annulus
US20210137579A1 (en) Tissue excision, cutting, and removal systems and methods
US20110257461A1 (en) Ventricular function assisting device and a method and apparatus for implanting it
JP2011510797A (ja) 多重窓ガイドトンネル
WO2017205358A1 (fr) Rapprochement de feuillet de valvule mitrale postérieure
CN211934206U (zh) 瓣膜组织切割装置及瓣膜夹钳回收系统
WO2010070649A1 (fr) Corps allongé pour son déploiement dans un sinus coronaire
WO2020236417A1 (fr) Ancrage expansible pour dispositifs de réparation de valvules cardiaques
US20230414357A1 (en) Method And Device For Removing Heart Valve Therapy
US12109110B2 (en) Percutaneous tricuspid valve repair devices and methods
WO2023137497A2 (fr) Méthode et dispositif pour le retrait d'une thérapie valvulaire cardiaque
CN116648200A (zh) 用于移除心脏瓣膜疗法的方法和装置
JP2012101094A (ja) 心臓弁修復のための送達装置および方法
CN113116468A (zh) 瓣膜组织切割装置及瓣膜夹钳回收系统

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230329

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: AMX TECHNOLOGIES, LLC

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)